| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/10/2002 | WO2002036792A2 Dna expression vectors |
| 05/10/2002 | WO2002036790A2 Influenza virus vector for infection of dendritic cells |
| 05/10/2002 | WO2002036788A2 Nucleic acids and polypeptides specifically expressed in cells of the transfer zone of a plant seed and uses thereof |
| 05/10/2002 | WO2002036785A1 Protein complexes and process for producing the same |
| 05/10/2002 | WO2002036777A1 aopB GENE, PROTEIN, HOMOLOGS, FRAGMENTS AND VARIANTS THEREOF, AND THEIR USE FOR CELL SURFACE DISPLAY |
| 05/10/2002 | WO2002036776A1 Improvement of plant flower type targeting mads box gene |
| 05/10/2002 | WO2002036775A1 A novel plant agglutinin gene |
| 05/10/2002 | WO2002036774A2 Derivatives of the human macrophage-migration inhibition factor (mif) and use thereof in pharmaceutical preparations in screening methods or the identification of analogues, agonists and antagonists |
| 05/10/2002 | WO2002036773A2 Nod2 nucleic acids and proteins |
| 05/10/2002 | WO2002036772A1 Novel disease-associated gene and use thereof |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036770A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | WO2002036769A2 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof |
| 05/10/2002 | WO2002036768A1 Cell division autoantigen (cda) polypeptides, gene sequences and uses thereof |
| 05/10/2002 | WO2002036766A2 Protein-protein complexes and methods of using same |
| 05/10/2002 | WO2002036763A1 Novel gene overexpressed in heart and skeletal muscle and use tehreof |
| 05/10/2002 | WO2002036762A1 Process for producing peptide |
| 05/10/2002 | WO2002036761A2 Compositions and methods for the diagnosis of cancer |
| 05/10/2002 | WO2002036747A2 Peripheral nerve type sodium channels |
| 05/10/2002 | WO2002036736A2 Alpha-tocopherol transfer protein knockout animals |
| 05/10/2002 | WO2002036733A2 Cd36 as a heat shock protein receptor and uses thereof |
| 05/10/2002 | WO2002036732A2 Active variants of fgf with improved specificity |
| 05/10/2002 | WO2002036634A2 Gene regulation therapy involving ferritin |
| 05/10/2002 | WO2002036633A2 Human 7tm proteins and polynucleotides encoding the same |
| 05/10/2002 | WO2002036632A2 Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides |
| 05/10/2002 | WO2002036630A2 Renin and/or proprenin receptor protein, nucleic acid coding for same and uses thereof |
| 05/10/2002 | WO2002036629A2 Regulation of human serotonin receptor precursor |
| 05/10/2002 | WO2002036628A2 New multimeric interferon beta polypeptides |
| 05/10/2002 | WO2002036627A2 Interferons, uses and compositions related thereto |
| 05/10/2002 | WO2002036626A1 Single-chain multimeric polypeptides |
| 05/10/2002 | WO2002036625A2 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | WO2002036624A2 Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof |
| 05/10/2002 | WO2002036623A2 Ghep, a gene highly expressed in normal and neoplastic prostate, and uses therefor |
| 05/10/2002 | WO2002036622A2 GαqPROETIN VARIANTS AND THEIR USE IN THE ANALYSIS AND DISCOVERY OF AGONISTS AND ANTAGONISTS OF CHEMOSENSORY RECEPTORS |
| 05/10/2002 | WO2002036621A1 Medical and diagnostic use of a specific co-activator for human nuclear receptors |
| 05/10/2002 | WO2002036620A2 Ets-transcription factor related compound specific promoter and transactivators thereof |
| 05/10/2002 | WO2002036619A1 A new polypeptide-human glycoprotein 42 and the polynucleotide encoding it |
| 05/10/2002 | WO2002036618A1 Novel genes encoding g and m1 proteins of a korean isolate ihnv-scs and a vaccine therefrom against infectious hematopoietic necrosis virus in salmonid fish |
| 05/10/2002 | WO2002036617A2 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 05/10/2002 | WO2002036616A2 Compositions and methods relating to breast specific genes and proteins |
| 05/10/2002 | WO2002036615A2 Methods for producing and improving therapeutic potency of binding polypeptides |
| 05/10/2002 | WO2002036614A2 Peptides for use in the treatment of alzheimer's disease |
| 05/10/2002 | WO2002036613A2 Regulation of human patched-like protein |
| 05/10/2002 | WO2002036612A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 05/10/2002 | WO2002036611A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | WO2002036610A2 Haplotypes of the adora3 gene |
| 05/10/2002 | WO2002036609A2 Haplotypes of the chrm4 gene |
| 05/10/2002 | WO2002036603A2 Nucleic acid sequence for a human beta tubulin |
| 05/10/2002 | WO2002036172A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 05/10/2002 | WO2002036167A1 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 05/10/2002 | WO2002036161A2 Novel targeted compositions for diagnostic and therapeutic use |
| 05/10/2002 | WO2002036160A2 Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/10/2002 | WO2002036154A2 Procollagen (iii) propeptides and related substances for treating fibrotic diseases |
| 05/10/2002 | WO2002036152A1 Use of il-1 inhibitors and tnf antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia |
| 05/10/2002 | WO2002036149A2 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof |
| 05/10/2002 | WO2002036146A2 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy |
| 05/10/2002 | WO2002036143A1 Inhibition or reversal of skin aging by actin-sequestering peptides |
| 05/10/2002 | WO2002036142A2 Compositions for inhibiting grb7 |
| 05/10/2002 | WO2002036131A1 In vivo stimulation of angiogenic activity |
| 05/10/2002 | WO2002036075A2 Small molecule compositions for binding to hsp90 |
| 05/10/2002 | WO2002036070A2 Novel fish chemokine and methods for use |
| 05/10/2002 | WO2002035981A2 Methods and compositions for the treatment of human immunodeficiency virus infection |
| 05/10/2002 | WO2002035923A1 Hypertension |
| 05/10/2002 | WO2002022798A3 Modulation of homologous recombination with single stranded dna binding proteins |
| 05/10/2002 | WO2002014468A3 Phage-dependent superproduction of biologically active protein and peptides |
| 05/10/2002 | WO2002011743B1 Treatment of prostate cancer |
| 05/10/2002 | WO2002009641A3 Promyostatin peptides and methods of using same |
| 05/10/2002 | WO2002007676A3 Compounds having affinity for the granulocyte-colony stimulating factor receptor (g-csfr) |
| 05/10/2002 | WO2002004492A3 Herpes zinc finger motifs |
| 05/10/2002 | WO2002002632A3 Modulation of tetraspanin function |
| 05/10/2002 | WO2002002608A3 NEW SODIUM CHANNEL (rNaV1.5a) AND USE THEREOF |
| 05/10/2002 | WO2002000885A9 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 05/10/2002 | WO2002000824A3 A NOVEL POLYPEPTIDE, A HUMAN tre ONCOGENE 10.56 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 05/10/2002 | WO2002000823A3 A novel polypeptide, a enzymatic activation protein ras gtp 9.57 and the polynucleotide encoding the polypeptide |
| 05/10/2002 | WO2002000821A3 A novel polypeptide, a human protein plp39 and the polynucleotide encoding the polypeptide |
| 05/10/2002 | WO2001098514A3 Targeting viral vectors to specific cells |
| 05/10/2002 | WO2001098338A3 Fluorescent proteins |
| 05/10/2002 | WO2001096578A3 Protein production in aureobasidium pullulans |
| 05/10/2002 | WO2001096526A3 A novel polypeptide, a human tumor suppressor factor 11.77 and the polynucleotide encoding the polypeptide |
| 05/10/2002 | WO2001096525A3 A novel polypeptide, a pogo conversion unit 18 and the polynucleotide encoding the polypeptide |
| 05/10/2002 | WO2001094949A3 Soluble cd1 compositions and uses thereof |
| 05/10/2002 | WO2001094563A3 46980, a novel human neuroligin family member and uses thereof |
| 05/10/2002 | WO2001094421A3 Method for electrophoretically separating membrane proteins |
| 05/10/2002 | WO2001094385A3 Human hm74-like g protein coupled receptor |
| 05/10/2002 | WO2001092337A3 Soluble ctla4 mutant molecules and uses thereof |
| 05/10/2002 | WO2001090304A3 Nucleic acids, proteins, and antibodies |
| 05/10/2002 | WO2001088116A3 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 05/10/2002 | WO2001087931A3 Bacterial insecticidal proteins |
| 05/10/2002 | WO2001085993A3 Method for detecting growth hormone variations in humans, the variations and their uses |
| 05/10/2002 | WO2001085201A3 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 05/10/2002 | WO2001083750A3 Dendritic cell co-stimulator molecules |
| 05/10/2002 | WO2001079516A3 Maize cellulose synthases and uses thereof |
| 05/10/2002 | WO2001079295A3 20716, a g-protein coupled receptor and uses therefor |
| 05/10/2002 | WO2001079288A3 Cytokine uses; compositions; methods |
| 05/10/2002 | WO2001077156A3 Neutralizing immunogenic hev polypeptides |
| 05/10/2002 | WO2001077145A3 Integrin binding peptide derivatives |
| 05/10/2002 | WO2001076639A3 Chemically-modified myelopoietin conjugates |
| 05/10/2002 | WO2001075116A3 ISOLATED NUCLEIC ACIDS FROM MICROMONOSPORA ROSARIA PLASMID pMR2 AND VECTORS MADE THEREFROM |
| 05/10/2002 | WO2001075029A3 A novel polypeptide, nf-e2-associated human factor 11 and the polynucleotide encoding the polypeptide |
| 05/10/2002 | WO2001074845A3 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof |